Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
106.00
-3.00 (-2.75%)
At close: Dec 5, 2025

Handa Pharmaceuticals Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
683.16472.74726.89-40.01-247.67-282.1
Upgrade
Depreciation & Amortization
125.4610.1612.1514.8216.4916.59
Upgrade
Other Amortization
0.270.270.30.3618.6739.4
Upgrade
Loss (Gain) From Sale of Assets
0.160.19-4.610-0.020
Upgrade
Asset Writedown & Restructuring Costs
-----4.5
Upgrade
Loss (Gain) on Equity Investments
-0.821.81-2.37---
Upgrade
Stock-Based Compensation
13.4822.398.470.110.260.64
Upgrade
Other Operating Activities
-32.7-189.2351.87-5.55-13.62-38.04
Upgrade
Change in Accounts Receivable
-679.21207.08-226.18-140.5813.41-2.25
Upgrade
Change in Inventory
39.28--10.11--
Upgrade
Change in Accounts Payable
61.496.578.345.1-8.26-4.66
Upgrade
Change in Other Net Operating Assets
-16.31-34.3893.51-55.9341.51-42.55
Upgrade
Operating Cash Flow
194.26497.6668.36-211.57-179.24-308.47
Upgrade
Operating Cash Flow Growth
-66.27%-25.55%----
Upgrade
Capital Expenditures
-18.62-7.77-0.94-0.64-5.58-7.41
Upgrade
Sale of Property, Plant & Equipment
-0-00.03-
Upgrade
Cash Acquisitions
-975.74-819.63----
Upgrade
Divestitures
---10.97---
Upgrade
Sale (Purchase) of Intangibles
-0.17---0.12-1.57-
Upgrade
Investment in Securities
-63.98431.12-1,65330.713.98189.21
Upgrade
Other Investing Activities
0.18-0.65--0.450.23-0.08
Upgrade
Investing Cash Flow
-1,058-396.92-1,66529.5-2.91181.72
Upgrade
Short-Term Debt Issued
-----4.6
Upgrade
Total Debt Issued
-----4.6
Upgrade
Short-Term Debt Repaid
------4.6
Upgrade
Long-Term Debt Repaid
--6.07-7.17-7.19-7.77-8.1
Upgrade
Total Debt Repaid
-13.37-6.07-7.17-7.19-7.77-12.7
Upgrade
Net Debt Issued (Repaid)
-13.37-6.07-7.17-7.19-7.77-8.1
Upgrade
Issuance of Common Stock
1,1583.121,313320.83170.682.74
Upgrade
Repurchase of Common Stock
-66.43-56.52----
Upgrade
Common Dividends Paid
-236.3-141.09----
Upgrade
Financing Cash Flow
841.49-200.551,306313.65162.91-5.36
Upgrade
Foreign Exchange Rate Adjustments
30.9630.2-8.34-28.972.441.75
Upgrade
Net Cash Flow
8.39-69.67301.13102.6-16.81-130.37
Upgrade
Free Cash Flow
175.65489.84667.42-212.21-184.82-315.88
Upgrade
Free Cash Flow Growth
-69.25%-26.61%----
Upgrade
Free Cash Flow Margin
10.86%58.97%60.33%-107.35%-632.19%-1094.57%
Upgrade
Free Cash Flow Per Share
1.173.474.95-1.69-1.57-2.73
Upgrade
Cash Interest Paid
0.930.490.220.280.230.45
Upgrade
Cash Income Tax Paid
199.74197.467.782.420.45-0.03
Upgrade
Levered Free Cash Flow
-438.42450.86-224.91-74.36-175.3
Upgrade
Unlevered Free Cash Flow
-438.73450.99-224.74-74.21-175.02
Upgrade
Change in Working Capital
-594.75179.27-124.33-181.3146.66-49.46
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.